GSK to link with Singapore on strategic "roadmap"
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline's new CEO, Andrew Witty, is building on his ties to Singapore in unveiling a new initiative with the Asian city-state to identify opportunities in the healthcare sector.